Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Moehler, Markus H.; Janjigian, Yelena Yuriy; Adenis, Antoine et al.
CheckMate 649: A randomized, multicenter, open-label, phase III study of nivolumab (NIVO) plus ipilimumab (IPI) or nivo plus chemotherapy (CTX) versus CTX alone in patients with previously untreated advanced (Adv) gastric (G) or gastroesophageal junction (GEJ) cancer.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 4. 2018
Mahmoudpour, Seyed Hamidreza; Bandapalli, Obul Reddy; da Silva Filho, Miguel Inacio et al.
Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patientsBMC CANCER. Bd. 18. 2018
Kindler, Thomas
CHIPing out PPM1D-mutant hematopoiesisBLOOD. Bd. 132. H. 11. 2018 S. 1087-1088
Moehler, M.; Maderer, A.; Thuss-Patience, P. et al.
Cisplatin/5-fluorouracil plus /- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker programANNALS OF ONCOLOGY. Bd. 29. 2018
Panova-Noeva, M.; Schulz, A.; Arnold, N. et al.
Coagulation and inflammation in long-term cancer survivors: results from the adult populationJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 16. H. 4. 2018 S. 699-708
Dahlhaus, Anne; Siebenhofer, Andrea; Guethlin, Corina et al.
Colorectal cancer stage at diagnosis in migrants and non-migrants: a cross-sectional analysis of the KoMigra Study in GermanyZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 56. H. 12. 2018 S. 1499-1506
Bartlett, John M. S.; Bayani, Jane; Kornaga, Elizabeth et al.
Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?CANCER RESEARCH. Bd. 78. H. 4. 2018
Korfei, Martina; Stelmaszek, Daniel; MacKenzie, BreAnne et al.
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosisPLOS ONE. Bd. 13. H. 11. 2018
Jurczak, Wojciech; Ramanathan, Sundra; Giri, Pratyush et al.
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphomaLEUKEMIA & LYMPHOMA. Bd. 59. H. 3. 2018 S. 670-678
Stintzing, S.; Lenz, H. -J.; Neureiter, D. et al.
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and 1st-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE-3 (AIO KRK-0306) trialONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 8-9